1887

Abstract

Cardiovascular disease is still the major cause of death worldwide despite the remarkable progress in its prevention and treatment. Endothelial progenitor cells (EPCs) have recently emerged as key players of vascular repair and regenerative medicine applied to cardiovascular disease. A large amount of effort has been put into discovering the factors that could aid or impair the number and function of EPCs, and also into characterizing these cells at the molecular level in order to facilitate their therapeutic applications in vascular disease. Interestingly, the major cardiovascular risk factors have been associated with reduced number and function of EPCs. The bacterial contribution to cardiovascular disease represents a long-standing controversy. The discovery that can infect and damage EPCs revitalizes the enduring debate about the microbiological contribution to atherosclerosis, thus allowing the hypothesis that this infection could impair the cardiovascular regenerative potential and increase the risk for cardiovascular disease. In this review, we summarize the rationale suggesting that could favour atherogenesis by infecting and damaging EPCs, thus reducing their vascular repair potential. These mechanisms suggest a novel link between communicable and non-communicable human diseases, and put forward the possibility that could enhance the susceptibility and worsen the prognosis in cardiovascular disease.

Loading

Article metrics loading...

/content/journal/jmm/10.1099/jmm.0.000099
2015-08-01
2024-03-29
Loading full text...

Full text loading...

/deliver/fulltext/jmm/64/8/799.html?itemId=/content/journal/jmm/10.1099/jmm.0.000099&mimeType=html&fmt=ahah

References

  1. Ameriso S.F., Fridman E.A., Leiguarda R.C., Sevlever G.E., Spence J.D. 2001; Detection of Helicobacter pylori in human carotid atherosclerotic plaques. Stroke 32:385–391 [View Article][PubMed]
    [Google Scholar]
  2. Aoki J., Serruys P.W., van Beusekom H., Ong A.T., McFadden E.P., Sianos G., van der Giessen W.J., Regar E., de Feyter P.J., other authors. 2005; Endothelial progenitor cell capture by stents coated with antibody against CD34: the HEALING-FIM (healthy endothelial accelerated lining inhibits neointimal growth-first in man) registry. J Am Coll Cardiol 45:1574–1579 [View Article][PubMed]
    [Google Scholar]
  3. Asahara T., Murohara T., Sullivan A., Silver M., van der Zee R., Li T., Witzenbichler B., Schatteman G., Isner J.M. 1997; Isolation of putative progenitor endothelial cells for angiogenesis. Science 275:964–966 [View Article][PubMed]
    [Google Scholar]
  4. Asahara T., Kawamoto A., Masuda H. 2011; Concise review: circulating endothelial progenitor cells for vascular medicine. Stem Cells 29:1650–1655 [View Article][PubMed]
    [Google Scholar]
  5. Assmus B., Schächinger V., Teupe C., Britten M., Lehmann R., Döbert N., Grünwald F., Aicher A., Urbich C., other authors. 2002; Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction (TOPCARE-AMI). Circulation 106:3009–3017 [View Article][PubMed]
    [Google Scholar]
  6. Barsotti M.C., Di Stefano R., Spontoni P., Chimenti D., Balbarini A. 2009; Role of endothelial progenitor cell mobilization after percutaneous angioplasty procedure. Curr Pharm Des 15:1107–1122 [View Article][PubMed]
    [Google Scholar]
  7. Becher M.U., Nickenig G., Werner N. 2010; Regeneration of the vascular compartment. Herz 35:342–351 [View Article][PubMed]
    [Google Scholar]
  8. Brouqui P., Raoult D. 2001; Endocarditis due to rare and fastidious bacteria. Clin Microbiol Rev 14:177–207 [View Article][PubMed]
    [Google Scholar]
  9. Cannon C.P., Braunwald E., McCabe C.H., Grayston J.T., Muhlestein B., Giugliano R.P., Cairns R., Skene A.M. 2005; Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators Antibiotic treatment of Chlamydia pneumoniae after acute coronary syndrome. N Engl J Med 352:1646–1654 [View Article][PubMed]
    [Google Scholar]
  10. Carmeliet P. 2000; Mechanisms of angiogenesis and arteriogenesis. Nat Med 6:389–395 [View Article][PubMed]
    [Google Scholar]
  11. Casamassimi A., Grimaldi V., Infante T., Al-Omran M., Crudele V., Napoli C. 2012; Adult stem cells and the clinical arena: are we able to widely use this therapy in patients with chronic limbs arteriopathy and ischemic ulcers without possibility of revascularization?. Cardiovasc Hematol Agents Med Chem 10:99–108 [View Article][PubMed]
    [Google Scholar]
  12. Chatzidimitriou D., Kirmizis D., Gavriilaki E., Chatzidimitriou M., Malisiovas N. 2012; Atherosclerosis and infection: is the jury still not in?. Future Microbiol 7:1217–1230 [View Article][PubMed]
    [Google Scholar]
  13. Chiaraviglio L., Duong S., Brown D.A., Birtles R.J., Kirby J.E. 2010; An immunocompromised murine model of chronic Bartonella infection. Am J Pathol 176:2753–2763 [View Article][PubMed]
    [Google Scholar]
  14. Chomel B.B., Kasten R.W., Williams C., Wey A.C., Henn J.B., Maggi R., Carrasco S., Mazet J., Boulouis H.J., other authors. 2009; Bartonella endocarditis: a pathology shared by animal reservoirs and patients. Ann N Y Acad Sci 1166:120–126 [View Article][PubMed]
    [Google Scholar]
  15. Chou H.H., Yumoto H., Davey M., Takahashi Y., Miyamoto T., Gibson F.C. III, Genco C.A. 2005; Porphyromonas gingivalis fimbria-dependent activation of inflammatory genes in human aortic endothelial cells. Infect Immun 73:5367–5378 [View Article][PubMed]
    [Google Scholar]
  16. Costa V., Sommese L., Casamassimi A., Colicchio R., Angelini C., Marchesano V., Milone L., Farzati B., Giovane A., other authors. 2010; Impairment of circulating endothelial progenitors in Down syndrome. BMC Med Genomics 3:40 [View Article][PubMed]
    [Google Scholar]
  17. de Nigris F., Williams-Ignarro S., Lerman L.O., Crimi E., Botti C., Mansueto G., D'Armiento F.P., De Rosa G., Sica V., other authors. 2005; Beneficial effects of pomegranate juice on oxidation-sensitive genes and endothelial nitric oxide synthase activity at sites of perturbed shear stress. Proc Natl Acad Sci U S A 102:4896–4901 [View Article][PubMed]
    [Google Scholar]
  18. Dehio C. 2001; Bartonella interactions with endothelial cells and erythrocytes. Trends Microbiol 9:279–285 [View Article][PubMed]
    [Google Scholar]
  19. Dehio C. 2008; Infection-associated type IV secretion systems of Bartonella and their diverse roles in host cell interaction. Cell Microbiol 10:1591–1598 [View Article][PubMed]
    [Google Scholar]
  20. Deng H., Le Rhun D., Buffet J.P., Cotté V., Read A., Birtles R.J., Vayssier-Taussat M. 2012; Strategies of exploitation of mammalian reservoirs by Bartonella species. Vet Res 43:15 [View Article][PubMed]
    [Google Scholar]
  21. Desvarieux M., Demmer R.T., Rundek T., Boden-Albala B., Jacobs D.R. Jr, Sacco R.L., Papapanou P.N. 2005; Periodontal microbiota and carotid intima-media thickness: the Oral Infections and Vascular Disease Epidemiology Study (INVEST). Circulation 111:576–582 [View Article][PubMed]
    [Google Scholar]
  22. Dimopoulos S., Eleftherakis E., Charitos C., Sakellaridis T., Sinapidis D., Kostis E., Toumanidis S., Efstathiou E. 2012; Bartonella quintana endocarditis as a cause of severe aortic insufficiency and heart failure. Hellenic J Cardiol 53:476–479[PubMed]
    [Google Scholar]
  23. Duda D.G., Cohen K.S., Scadden D.T., Jain R.K. 2007; A protocol for phenotypic detection and enumeration of circulating endothelial cells and circulating progenitor cells in human blood. Nat Protoc 2:805–810 [View Article][PubMed]
    [Google Scholar]
  24. Duewell P., Kono H., Rayner K.J., Sirois C.M., Vladimer G., Bauernfeind F.G., Abela G.S., Franchi L., Nuñez G. other authors 2010; NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 464:1357–1361 [View Article][PubMed]
    [Google Scholar]
  25. Epstein S.E., Zhu J., Najafi A.H., Burnett M.S. 2009; Insights into the role of infection in atherogenesis and in plaque rupture. Circulation 119:3133–3141 [View Article][PubMed]
    [Google Scholar]
  26. Espinola-Klein C., Rupprecht H.J., Blankenberg S., Bickel C., Kopp H., Rippin G., Victor A., Hafner G., Schlumberger W., other authors. 2002; Impact of infectious burden on extent and long-term prognosis of atherosclerosis. Circulation 105:15–21 [View Article][PubMed]
    [Google Scholar]
  27. Fabricant C.G., Krook L., Gillespie J.H. 1973; Virus-induced cholesterol crystals. Science 181:566–567 [View Article][PubMed]
    [Google Scholar]
  28. Fabricant C.G., Fabricant J., Litrenta M.M., Minick C.R. 1978; Virus-induced atherosclerosis. J Exp Med 148:335–340 [View Article][PubMed]
    [Google Scholar]
  29. Falagas M.E., Makris G.C., Matthaiou D.K., Rafailidis P.I. 2008; Statins for infection and sepsis: a systematic review of the clinical evidence. J Antimicrob Chemother 61:774–785 [View Article][PubMed]
    [Google Scholar]
  30. Fiehn N.E., Larsen T., Christiansen N., Holmstrup P., Schroeder T.V. 2005; Identification of periodontal pathogens in atherosclerotic vessels. J Periodontol 76:731–736 [View Article][PubMed]
    [Google Scholar]
  31. Fournier P.E., Lelievre H., Eykyn S.J., Mainardi J.L., Marrie T.J., Bruneel F., Roure C., Nash J., Clave D., other authors. 2001; Epidemiologic and clinical characteristics of Bartonella quintana Bartonella henselae endocarditis: a study of 48 patients. Medicine (Baltimore) 80:245–251 [View Article][PubMed]
    [Google Scholar]
  32. Franceschi F., Sepulveda A.R., Gasbarrini A., Pola P., Silveri N.G., Gasbarrini G., Graham D.Y., Genta R.M. 2002; Cross-reactivity of anti-CagA antibodies with vascular wall antigens: possible pathogenic link between Helicobacter pylori infection and atherosclerosis. Circulation 106:430–434 [View Article][PubMed]
    [Google Scholar]
  33. Friedrich E.B., Walenta K., Scharlau J., Nickenig G., Werner N. 2006; CD34 − /CD133+/VEGFR-2+ endothelial progenitor cell subpopulation with potent vasoregenerative capacities. Circ Res 98:e20–e25 [View Article][PubMed]
    [Google Scholar]
  34. Fuhrmann O., Arvand M., Göhler A., Schmid M., Krüll M., Hippenstiel S., Seybold J., Dehio C., Suttorp N. 2001; Bartonella henselae induces NF-kappaB-dependent upregulation of adhesion molecules in cultured human endothelial cells: possible role of outer membrane proteins as pathogenic factors. Infect Immun 69:5088–5097 [View Article][PubMed]
    [Google Scholar]
  35. García J.C., Núñez M.J., Castro B., Fernández J.M., López A., Portillo A., Oteo J.A. 2014; Hepatosplenic cat scratch disease in immunocompetent adults: report of 3 cases and review of the literature. Medicine (Baltimore) 93:267–279 [View Article][PubMed]
    [Google Scholar]
  36. George A.L., Bangalore-Prakash P., Rajoria S., Suriano R., Shanmugam A., Mittelman A., Tiwari R.K. 2011; Endothelial progenitor cell biology in disease and tissue regeneration. J Hematol Oncol 4:24 [View Article][PubMed]
    [Google Scholar]
  37. González I., Sarriá C., López J., Vilacosta I., San Román A., Olmos C., Sáez C., Revilla A., Hernández M., other authors. 2014; Symptomatic peripheral mycotic aneurysms due to infective endocarditis: a contemporary profile. Medicine (Baltimore) 93:42–52 [View Article][PubMed]
    [Google Scholar]
  38. Grayston J.T. 2000; Background and current knowledge of Chlamydia pneumoniae and atherosclerosis. J Infect Dis 181:(Suppl. 3)S402–S410 [View Article][PubMed]
    [Google Scholar]
  39. Grayston J.T., Kronmal R.A., Jackson L.A., Parisi A.F., Muhlestein J.B., Cohen J.D., Rogers W.J., Crouse J.R., Borrowdale S.L., other authors. 2005; Azithromycin for the secondary prevention of coronary events. N Engl J Med 352:1637–1645 [View Article][PubMed]
    [Google Scholar]
  40. Gyan B., Goka B.Q., Adjei G.O., Tetteh J.K., Kusi K.A., Aikins A., Dodoo D., Lesser M.L., Sison C.P., other authors. 2009; Cerebral malaria is associated with low levels of circulating endothelial progenitor cells in African children. Am J Trop Med Hyg 80:541–546[PubMed]
    [Google Scholar]
  41. Hajjar D.P., Fabricant C.G., Minick C.R., Fabricant J. 1986; Virus-induced atherosclerosis. Herpesvirus infection alters aortic cholesterol metabolism and accumulation. Am J Pathol 122:62–70[PubMed]
    [Google Scholar]
  42. Harms A., Dehio C. 2012; Intruders below the radar: molecular pathogenesis of Bartonella spp. Clin Microbiol Rev 25:42–78 [View Article][PubMed]
    [Google Scholar]
  43. He C., Yang Z., Lu N-H. 2014; Helicobacter pylori-an infectious risk factor for atherosclerosis?. J Atheroscler Thromb 21:1229–1242 [View Article][PubMed]
    [Google Scholar]
  44. Hirschi K.K., Ingram D.A., Yoder M.C. 2008; Assessing identity, phenotype, and fate of endothelial progenitor cells. Arterioscler Thromb Vasc Biol 28:1584–1595 [View Article][PubMed]
    [Google Scholar]
  45. Hristov M., Weber C. 2006; The therapeutic potential of progenitor cells in ischemic heart disease—past, present and future. Basic Res Cardiol 101:1–7 [View Article][PubMed]
    [Google Scholar]
  46. Hur J., Yoon C.H., Kim H.S., Choi J.H., Kang H.J., Hwang K.K., Oh B.H., Lee M.M., Park Y.B. 2004; Characterization of two types of endothelial progenitor cells and their different contributions to neovasculogenesis. Arterioscler Thromb Vasc Biol 24:288–293 [View Article][PubMed]
    [Google Scholar]
  47. Kaiser P.O., Riess T., O'Rourke F., Linke D., Kempf V.A. 2011; Bartonella spp.: throwing light on uncommon human infections. Int J Med Microbiol 301:7–15 [View Article][PubMed]
    [Google Scholar]
  48. Katsouli A., Massad M.G. 2013; Current issues in the diagnosis and management of blood culture-negative infective and non-infective endocarditis. Ann Thorac Surg 95:1467–1474 [View Article][PubMed]
    [Google Scholar]
  49. Kawamoto A., Tkebuchava T., Yamaguchi J., Nishimura H., Yoon Y.S., Milliken C., Uchida S., Masuo O., Iwaguro H., other authors. 2003; Intramyocardial transplantation of autologous endothelial progenitor cells for therapeutic neovascularization of myocardial ischemia. Circulation 107:461–468 [View Article][PubMed]
    [Google Scholar]
  50. Kempf V.A., Volkmann B., Schaller M., Sander C.A., Alitalo K., Rieß T., Autenrieth I.B. 2001; Evidence of a leading role for VEGF in Bartonella henselae-induced endothelial cell proliferations. Cell Microbiol 3:623–632 [View Article][PubMed]
    [Google Scholar]
  51. Kirby J.E., Nekorchuk D.M. 2002; Bartonella-associated endothelial proliferation depends on inhibition of apoptosis. Proc Natl Acad Sci U S A 99:4656–4661 [View Article][PubMed]
    [Google Scholar]
  52. Koehler J.E., Sanchez M.A., Garrido C.S., Whitfeld M.J., Chen F.M., Berger T.G., Rodriguez-Barradas M.C., LeBoit P.E., Tappero J.W. 1997; Molecular epidemiology of bartonella infections in patients with bacillary angiomatosis-peliosis. N Engl J Med 337:1876–1883 [View Article][PubMed]
    [Google Scholar]
  53. Kolb-Mäurer A., Wilhelm M., Weissinger F., Bröcker E.B., Goebel W. 2002; Interaction of human hematopoietic stem cells with bacterial pathogens. Blood 100:3703–3709 [View Article][PubMed]
    [Google Scholar]
  54. Kozarov E. 2012; Bacterial invasion of vascular cell types: vascular infectology and atherogenesis. Future Cardiol 8:123–138 [View Article][PubMed]
    [Google Scholar]
  55. Kozarov E., Li L., Michel R., Rodriguez R., DeCarlo A.A. 2003; Differential activity of P. gingivalis-secreted proteins toward polarized human endothelial cells. J Dent Res 82:B180
    [Google Scholar]
  56. Kozarov E.V., Dorn B.R., Shelburne C.E., Dunn W.A. Jr, Progulske-Fox A. 2005; Human atherosclerotic plaque contains viable invasive Actinobacillus actinomycetemcomitans Porphyromonas gingivalis . Arterioscler Thromb Vasc Biol 25:e17–e18 [View Article][PubMed]
    [Google Scholar]
  57. Kozarov E., Sweier D., Shelburne C., Progulske-Fox A., Lopatin D. 2006; Detection of bacterial DNA in atheromatous plaques by quantitative PCR. Microbes Infect 8:687–693 [View Article][PubMed]
    [Google Scholar]
  58. Kozarov E., Padro T., Badimon L. 2014; View of statins as antimicrobials in cardiovascular risk modification. Cardiovasc Res 102:362–374 [View Article][PubMed]
    [Google Scholar]
  59. Lamas C.C., Ramos R.G., Lopes G.Q., Santos M.S., Golebiovski W.F., Weksler C., Ferraiuoli G.I., Fournier P.E., Lepidi H., Raoult D. 2013; Bartonella Coxiella infective endocarditis in Brazil: molecular evidence from excised valves from a cardiac surgery referral center in Rio de Janeiro, Brazil, 1998 to 2009. Int J Infect Dis 17:e65–e66 [View Article][PubMed]
    [Google Scholar]
  60. Lasala G.P., Minguell J.J. 2009; Bone marrow-derived stem/progenitor cells: their use in clinical studies for the treatment of myocardial infarction. Heart Lung Circ 18:171–180 [View Article][PubMed]
    [Google Scholar]
  61. Leong S.S., Cazen R.A., Yu G.S., LeFevre L., Carson J.W. 1992; Abdominal visceral peliosis associated with bacillary angiomatosis. Ultrastructural evidence of endothelial destruction by bacilli. Arch Pathol Lab Med 116:866–871[PubMed]
    [Google Scholar]
  62. Libby P., Ridker P.M., Hansson G.K., Leducq Transatlantic Network on Atherothrombosis. 2009; Inflammation in atherosclerosis: from pathophysiology to practice. J Am Coll Cardiol 54:2129–2138 [View Article][PubMed]
    [Google Scholar]
  63. Magnus P., Beaglehole R. 2001; The real contribution of the major risk factors to the coronary epidemics: time to end the only-50% myth. Arch Intern Med 161:2657–2660 [View Article][PubMed]
    [Google Scholar]
  64. Maguiña C., Guerra H., Ventosilla P. 2009; Bartonellosis. Clin Dermatol 27:271–280 [View Article][PubMed]
    [Google Scholar]
  65. Mahmood A., Napoli C., Aldahmash A. 2011; In vitro differentiation and maturation of human embryonic stem cell into multipotent cells. Stem Cells Int 2011:735420 [View Article][PubMed]
    [Google Scholar]
  66. Mändle T., Einsele H., Schaller M., Neumann D., Vogel W., Autenrieth I.B., Kempf V.A. 2005; Infection of human CD34+ progenitor cells with Bartonella henselae results in intraerythrocytic presence of B. henselae . Blood 106:1215–1222 [View Article][PubMed]
    [Google Scholar]
  67. Martin-Rendon E., Brunskill S.J., Hyde C.J., Stanworth S.J., Mathur A., Watt S.M. 2008; Autologous bone marrow stem cells to treat acute myocardial infarction: a systematic review. Eur Heart J 29:1807–1818 [View Article][PubMed]
    [Google Scholar]
  68. Mathers C.D., Loncar D. 2006; Projections of global mortality and burden of disease from 2002 to 2030. PLoS Med 3:e442 [View Article][PubMed]
    [Google Scholar]
  69. Mayr M., Kiechl S., Willeit J., Wick G., Xu Q. 2000; Infections, immunity, and atherosclerosis: associations of antibodies to Chlamydia pneumoniae Helicobacter pylori, and cytomegalovirus with immune reactions to heat-shock protein 60 and carotid or femoral atherosclerosis. Circulation 102:833–839 [View Article][PubMed]
    [Google Scholar]
  70. Mayerl C., Lukasser M., Sedivy R., Niederegger H., Seiler R., Wick G. 2006; Atherosclerosis research from past to present - on the track of two pathologists with opposing views. Virchows Arch 449:96–103 [View Article][PubMed]
    [Google Scholar]
  71. Melnick J.L., Adam E., Debakey M.E. 1993; Cytomegalovirus and atherosclerosis. Eur Heart J 14:30–38[PubMed]
    [Google Scholar]
  72. Miyamoto Y., Suyama T., Yashita T., Akimaru H., Kurata H. 2007; Bone marrow subpopulations contain distinct types of endothelial progenitor cells and angiogenic cytokine-producing cells. J Mol Cell Cardiol 43:627–635 [View Article][PubMed]
    [Google Scholar]
  73. Moroni G., Del Papa N., Moronetti L.M., Vitali C., Maglione W., Comina D.P., Urgnani F., Sandri S., Ponticelli C., Cortelezzi A. 2005; Increased levels of circulating endothelial cells in chronic periaortitis as a marker of active disease. Kidney Int 68:562–568 [View Article][PubMed]
    [Google Scholar]
  74. Mosepele M., Mazo D., Cohn J. 2012; Bartonella infection in immunocompromised hosts: immunology of vascular infection and vasoproliferation. Clin Dev Immunol 2012:612809 [View Article][PubMed]
    [Google Scholar]
  75. Napoli C., William-Ignarro S., Byrns R., Balestrieri M.L., Crimi E., Farzati B., Mancini F.P., de Nigris F., Matarazzo A., other authors. 2008; Therapeutic targeting of the stem cell niche in experimental hindlimb ischemia. Nat Clin Pract Cardiovasc Med 5:571–579 [View Article][PubMed]
    [Google Scholar]
  76. Nieto F.J. 2002; Infective agents and cardiovascular disease. Semin Vasc Med 2:401–416 [View Article][PubMed]
    [Google Scholar]
  77. O'Connor C.M., Dunne M.W., Pfeffer M.A., Muhlestein J.B., Yao L., Gupta S., Benner R.J., Fisher M.R., Cook T.D., Investigators in the WIZARD Study. 2003; Azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomized controlled trial. JAMA 290:1459–1466 [View Article][PubMed]
    [Google Scholar]
  78. Okujava R., Guye P., Lu Y.Y., Mistl C., Polus F., Vayssier-Taussat M., Halin C., Rolink A.G., Dehio C. 2014; A translocated effector required for bartonella dissemination from derma to blood safeguards migratory host cells from damage by co-translocated effectors. PLoS Pathog 10:e1004187 [View Article][PubMed]
    [Google Scholar]
  79. Otsui K., Inoue N., Kobayashi S., Shiraki R., Honjo T., Takahashi M., Hirata K., Kawashima S., Yokoyama M. 2007; Enhanced expression of TLR4 in smooth muscle cells in human atherosclerotic coronary arteries. Heart Vessels 22:416–422 [View Article][PubMed]
    [Google Scholar]
  80. Ott S.J., El Mokhtari N.E., Musfeldt M., Hellmig S., Freitag S., Rehman A., Kühbacher T., Nikolaus S., Namsolleck P., other authors. 2006; Detection of diverse bacterial signatures in atherosclerotic lesions of patients with coronary heart disease. Circulation 113:929–937 [View Article][PubMed]
    [Google Scholar]
  81. Peichev M., Naiyer A.J., Pereira D., Zhu Z., Lane W.J., Williams M., Oz M.C., Hicklin D.J., Witte L., other authors. 2000; Expression of VEGFR-2 and AC133 by circulating human CD34(+) cells identifies a population of functional endothelial precursors. Blood 95:952–958[PubMed]
    [Google Scholar]
  82. Picascia A., Pagliuca C., Sommese L., Colicchio R., Casamassimi A., Labonia F., Pastore G., Pagliarulo C., Cicatiello A.G., other authors. 2015; Seroprevalence of Bartonella henselae in patients awaiting heart transplant in Southern Italy. J Microbiol Immunol Infect [View Article][PubMed]
    [Google Scholar]
  83. Prasad A., Zhu J., Halcox J.P., Waclawiw M.A., Epstein S.E., Quyyumi A.A. 2002; Predisposition to atherosclerosis by infections: role of endothelial dysfunction. Circulation 106:184–190 [View Article][PubMed]
    [Google Scholar]
  84. Pulliainen A.T., Dehio C. 2009; Bartonella henselae: subversion of vascular endothelial cell functions by translocated bacterial effector proteins. Int J Biochem Cell Biol 41:507–510 [View Article][PubMed]
    [Google Scholar]
  85. Que Y.A., Moreillon P. 2011; Infective endocarditis. Nat Rev Cardiol 8:322–336 [View Article][PubMed]
    [Google Scholar]
  86. Relman D.A., Loutit J.S., Schmidt T.M., Falkow S., Tompkins L.S. 1990; The agent of bacillary angiomatosis. An approach to the identification of uncultured pathogens. N Engl J Med 323:1573–1580 [View Article][PubMed]
    [Google Scholar]
  87. Resto-Ruiz S.I., Schmiederer M., Sweger D., Newton C., Klein T.W., Friedman H., Anderson B.E. 2002; Induction of a potential paracrine angiogenic loop between human THP-1 macrophages and human microvascular endothelial cells during Bartonella henselae infection. Infect Immun 70:4564–4570 [View Article][PubMed]
    [Google Scholar]
  88. Ridker P.M. 2002; On evolutionary biology, inflammation, infection, and the causes of atherosclerosis. Circulation 105:2–4[PubMed]
    [Google Scholar]
  89. Ridker P.M., Paynter N.P., Rifai N., Gaziano J.M., Cook N.R. 2008 [View Article][PubMed] C-reactive protein and parental history improve global cardiovascular risk prediction: the Reynolds Risk Score for men. Circulation 118:2243–2251
    [Google Scholar]
  90. Rolain J.M., La Scola B., Liang Z., Davoust B., Raoult D. 2001; Immunofluorescent detection of intraerythrocytic Bartonella henselae in naturally infected cats. J Clin Microbiol 39:2978–2980 [View Article][PubMed]
    [Google Scholar]
  91. Rolain J.M., Maurin M., Mallet M.N., Parzy D., Raoult D. 2003; Culture and antibiotic susceptibility of Bartonella quintana in human erythrocytes. Antimicrob Agents Chemother 47:614–619 [View Article][PubMed]
    [Google Scholar]
  92. Rosenfeld M.E., Campbell L.A. 2011; Pathogens and atherosclerosis: update on the potential contribution of multiple infectious organisms to the pathogenesis of atherosclerosis. Thromb Haemost 106:858–867 [View Article][PubMed]
    [Google Scholar]
  93. Ross R. 1999; Atherosclerosis—an inflammatory disease. N Engl J Med 340:115–126 [View Article][PubMed]
    [Google Scholar]
  94. Roth G.A., Ankersmit H.J., Brown V.B., Papapanou P.N., Schmidt A.M., Lalla E. 2007; Porphyromonas gingivalis infection and cell death in human aortic endothelial cells. FEMS Microbiol Lett 272:106–113 [View Article][PubMed]
    [Google Scholar]
  95. Roth G.A., Aumayr K., Giacona M.B., Papapanou P.N., Schmidt A.M., Lalla E. 2009; Porphyromonas gingivalis infection and prothrombotic effects in human aortic smooth muscle cells. Thromb Res 123:780–784 [View Article][PubMed]
    [Google Scholar]
  96. Ryeom S., Folkman J. 2009; Role of endogenous angiogenesis inhibitors in Down syndrome. J Craniofac Surg 20:(Suppl. 1)595–596 [View Article][PubMed]
    [Google Scholar]
  97. Saikku P., Leinonen M., Mattila K., Ekman M.R., Nieminen M.S., Mäkelä P.H., Huttunen J.K., Valtonen V. 1988; Serological evidence of an association of a novel Chlamydia, TWAR, with chronic coronary heart disease and acute myocardial infarction. Lancet 332:983–986 [View Article][PubMed]
    [Google Scholar]
  98. Salvatore P., Casamassimi A., Sommese L., Fiorito C., Ciccodicola A., Rossiello R., Avallone B., Grimaldi V., Costa V., other authors. 2008; Detrimental effects of Bartonella henselae are counteracted by l-arginine and nitric oxide in human endothelial progenitor cells. Proc Natl Acad Sci U S A 105:9427–9432 [View Article][PubMed]
    [Google Scholar]
  99. Schächinger V., Assmus B., Britten M.B., Honold J., Lehmann R., Teupe C., Abolmaali N.D., Vogl T.J., Hofmann W.K., other authors. 2004; Transplantation of progenitor cells and regeneration enhancement in acute myocardial infarction: final one-year results of the TOPCARE-AMI trial. J Am Coll Cardiol 44:1690–1699 [View Article][PubMed]
    [Google Scholar]
  100. Schmid M.C., Schulein R., Dehio M., Denecker G., Carena I., Dehio C. 2004; The VirB type IV secretion system of Bartonella henselae mediates invasion, proinflammatory activation and antiapoptotic protection of endothelial cells. Mol Microbiol 52:81–92 [View Article][PubMed]
    [Google Scholar]
  101. Schmid M.C., Scheidegger F., Dehio M., Balmelle-Devaux N., Schulein R., Guye P., Chennakesava C.S., Biedermann B., Dehio C. 2006; A translocated bacterial protein protects vascular endothelial cells from apoptosis. PLoS Pathog 2:e115 [View Article][PubMed]
    [Google Scholar]
  102. Schülein R., Seubert A., Gille C., Lanz C., Hansmann Y., Piémont Y., Dehio C. 2001; Invasion and persistent intracellular colonization of erythrocytes. A unique parasitic strategy of the emerging pathogen Bartonella . J Exp Med 193:1077–1086 [View Article][PubMed]
    [Google Scholar]
  103. Sen S., McDonald S.P., Coates P.T., Bonder C.S. 2011; Endothelial progenitor cells: novel biomarker and promising cell therapy for cardiovascular disease. Clin Sci (Lond) 120:263–283[PubMed] [CrossRef]
    [Google Scholar]
  104. Serra e Silva Filho W., Casarin R.C., Nicolela E.L. Jr, Passos H.M., Sallum A.W., Gonçalves R.B. 2014; Microbial diversity similarities in periodontal pockets and atheromatous plaques of cardiovascular disease patients. PLoS One 9:e109761 [View Article][PubMed]
    [Google Scholar]
  105. Shantsila E., Watson T., Tse H.F., Lip G.Y. 2008; New insights on endothelial progenitor cell subpopulations and their angiogenic properties. J Am Coll Cardiol 51:669–671 [View Article][PubMed]
    [Google Scholar]
  106. Shi Q., Rafii S., Wu M.H., Wijelath E.S., Yu C., Ishida A., Fujita Y., Kothari S., Mohle R., other authors. 1998; Evidence for circulating bone marrow-derived endothelial cells. Blood 92:362–367[PubMed]
    [Google Scholar]
  107. Sieveking D.P., Buckle A., Celermajer D.S., Ng M.K. 2008; Strikingly different angiogenic properties of endothelial progenitor cell subpopulations: insights from a novel human angiogenesis assay. J Am Coll Cardiol 51:660–668 [View Article][PubMed]
    [Google Scholar]
  108. Sommese L., Pagliuca C., Avallone B., Ippolito R., Casamassimi A., Costa V., Colicchio R., Cerciello R., D'Armiento M., other authors. 2012; Evidence of Bacteroides fragilis protection from Bartonella henselae-induced damage. PLoS One 7:e49653 [View Article][PubMed]
    [Google Scholar]
  109. Stassen F.R., Vainas T., Bruggeman C.A. 2008; Infection and atherosclerosis. An alternative view on an outdated hypothesis. Pharmacol Rep 60:85–92[PubMed]
    [Google Scholar]
  110. Steinberg D. 2006; Thematic review series: the pathogenesis of atherosclerosis. An interpretive history of the cholesterol controversy, part V: the discovery of the statins and the end of the controversy. J Lipid Res 47:1339–1351 [View Article][PubMed]
    [Google Scholar]
  111. Sun H.Y., Singh N. 2009; Antimicrobial and immunomodulatory attributes of statins: relevance in solid-organ transplant recipients. Clin Infect Dis 48:745–755 [View Article][PubMed]
    [Google Scholar]
  112. Takahashi H., Shibuya M. 2005; The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin Sci (Lond) 109:227–241 [View Article][PubMed]
    [Google Scholar]
  113. Tateishi-Yuyama E., Matsubara H., Murohara T., Ikeda U., Shintani S., Masaki H., Amano K., Kishimoto Y., Yoshimoto K., other authors. 2002; Therapeutic angiogenesis for patients with limb ischaemia by autologous transplantation of bone-marrow cells: a pilot study and a randomised controlled trial. Lancet 360:427–435 [View Article][PubMed]
    [Google Scholar]
  114. Teofili L., Iachininoto M.G., Capodimonti S., Ucciferri C., Nuzzolo E.R., Martini M., Torti L., Falasca K., Vecchiet J., other authors. 2010; Endothelial progenitor cell trafficking in human immunodeficiency virus-infected persons. AIDS 24:2443–2450 [View Article][PubMed]
    [Google Scholar]
  115. Törmäkangas L., Erkkilä L., Korhonen T., Tiirola T., Bloigu A., Saikku P., Leinonen M. 2005; Effects of repeated Chlamydia pneumoniae inoculations on aortic lipid accumulation and inflammatory response in C57BL/6J mice. Infect Immun 73:6458–6466 [View Article][PubMed]
    [Google Scholar]
  116. Urbich C., Heeschen C., Aicher A., Dernbach E., Zeiher A.M., Dimmeler S. 2003; Relevance of monocytic features for neovascularization capacity of circulating endothelial progenitor cells. Circulation 108:2511–2516 [View Article][PubMed]
    [Google Scholar]
  117. Vanderheyden M., Vercauteren S., Mansour S., Delrue L., Vandekerckhove B., Heyndrickx G.R., Van Haute I., De Bruyne B., Timmermans F., other authors. 2007; Time-dependent effects on coronary remodeling and epicardial conductance after intracoronary injection of enriched hematopoietic bone marrow stem cells in patients with previous myocardial infarction. Cell Transplant 16:919–925 [View Article][PubMed]
    [Google Scholar]
  118. Varanat M., Maggi R.G., Linder K.E., Breitschwerdt E.B. 2013; Infection of human brain vascular pericytes (HBVPs) by Bartonella henselae . Med Microbiol Immunol (Berl) 202:143–151 [View Article][PubMed]
    [Google Scholar]
  119. Vis J.C., Duffels M.G., Winter M.M., Weijerman M.E., Cobben J.M., Huisman S.A., Mulder B.J. 2009; Down syndrome: a cardiovascular perspective. J Intellect Disabil Res 53:419–425 [View Article][PubMed]
    [Google Scholar]
  120. World Health Organization 2011 Global status report on noncommunicable diseases 2010 Geneva: World Health Organization;
    [Google Scholar]
  121. Yoder M.C. 2010; Is endothelium the origin of endothelial progenitor cells?. Arterioscler Thromb Vasc Biol 30:1094–1103 [View Article][PubMed]
    [Google Scholar]
  122. Yoder M.C., Mead L.E., Prater D., Krier T.R., Mroueh K.N., Li F., Krasich R., Temm C.J., Prchal J.T., Ingram D.A. 2007; Redefining endothelial progenitor cells via clonal analysis and hematopoietic stem/progenitor cell principals. Blood 109:1801–1809 [View Article][PubMed]
    [Google Scholar]
  123. Zähringer U., Lindner B., Knirel Y.A., van den Akker W.M., Hiestand R., Heine H., Dehio C. 2004; Structure and biological activity of the short-chain lipopolysaccharide from Bartonella henselae ATCC 49882T . J Biol Chem 279:21046–21054 [View Article]
    [Google Scholar]
http://instance.metastore.ingenta.com/content/journal/jmm/10.1099/jmm.0.000099
Loading
/content/journal/jmm/10.1099/jmm.0.000099
Loading

Data & Media loading...

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error